Cite

HARVARD Citation

    Kadriu, B. et al. (2018). Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. Journal of clinical psychopharmacology. 38 (3), p. . [Online]. 
  
Back to record